Ensysce Biosciences (ENSC) Current Assets (2017 - 2025)
Ensysce Biosciences (ENSC) recorded Current Assets of $7.25 million in Q4 2025, up 35.6% from $5.34 million a year earlier and up 147.4% from the prior quarter.
Powered by 
Analysis
Ensysce Biosciences (ENSC) Current Assets (2017 - 2025) Analysis & Trends
Starting with Q4 2017, Ensysce Biosciences' Current Assets history includes 33 quarters.
- Annual Current Assets has a five-year compound annual growth rate of 83.5% (FY2020 to FY2025).
- Across earlier years, Current Assets came in at $5.34 million in FY2024 (+133.5%), $2.29 million in FY2023 (-56.8%), $5.3 million in FY2022 (-66.2%) and $15.66 million in FY2021.
- The Q4 2025 figure is the highest quarterly Current Assets since Q3 2024.
- On a year-over-year basis, Current Assets rose in five of the last eight quarters, with growth averaging 52.6%.
- Peak year-over-year performance for Current Assets in the last five years was growth of 229.6% in Q3 2024, against a decline of 71.1% in Q1 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $2.93 million (Q3 2025), $5.28 million (Q2 2025) and $4.4 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 65.26 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 56.35 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 37.48 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 38.94 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 27.35 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 27.97 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 34.36 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 16.55 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 45.01 Bn |
| 10 | Ensysce Biosciences | 901,219.67 | -10.35 Mn | - | 7.25 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 7.25 Mn |
| Sep 30, 2025 | 2.93 Mn |
| Jun 30, 2025 | 5.28 Mn |
| Mar 31, 2025 | 4.40 Mn |
| Dec 31, 2024 | 5.34 Mn |
| Sep 30, 2024 | 9.09 Mn |
| Jun 30, 2024 | 2.46 Mn |
| Mar 31, 2024 | 4.70 Mn |
| Dec 31, 2023 | 2.29 Mn |
| Sep 30, 2023 | 2.76 Mn |
| Jun 30, 2023 | 5.86 Mn |
| Mar 31, 2023 | 3.37 Mn |
| Dec 31, 2022 | 5.30 Mn |
| Sep 30, 2022 | 7.66 Mn |
| Jun 30, 2022 | 7.19 Mn |
| Mar 31, 2022 | 11.66 Mn |
| Dec 31, 2021 | 15.66 Mn |
| Sep 30, 2021 | 8.92 Mn |
| Jun 30, 2021 | 8.36 Mn |
| Mar 31, 2021 | 228,213.00 |
API Access
Ensysce Biosciences Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=ENSC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "ENSC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=ENSC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();